Biosimilar Uptake Remains Variable, Posing Challenges to the Market

By Gina Shaw
Four key dynamics—coverage and access, average sales price, provider net cost recovery, and patient cost impact—affect the biosimilar market and pose a risk to the long-term sustainability of the infused biosimilar system, said Scott Biggs, the director of supplier services for IQVIA, at the NASP 2024 Annual Meeting & Expo, in Nashville, Tenn.